Описание
Evidence from clinical studies evaluating probiotic use in critically ill pediatric patients is summarized (part 3), documenting outcomes related to infection prevention, gut barrier integrity, and immune modulation.
Cite This Figure
![Figure 5: Evidence from clinical studies evaluating probiotic use in critically ill pediatric patients is summarized (part 3), documenting outcomes related to infection prevention, gut barrier integrity, and immune modulation.]() > Source: Sunit C Singhi et al. "Probiotics in critically ill children.." *F1000Research*, 2016. PMID: [27081478](https://pubmed.ncbi.nlm.nih.gov/27081478/)
<figure> <img src="" alt="Evidence from clinical studies evaluating probiotic use in critically ill pediatric patients is summarized (part 3), documenting outcomes related to infection prevention, gut barrier integrity, and immune modulation." /> <figcaption>Figure 5. Evidence from clinical studies evaluating probiotic use in critically ill pediatric patients is summarized (part 3), documenting outcomes related to infection prevention, gut barrier integrity, and immune modulation.<br> Source: Sunit C Singhi et al. "Probiotics in critically ill children.." <em>F1000Research</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27081478/">27081478</a></figcaption> </figure>